FDA inspection
Biotechpharma Biotechnologines Farmacijos Centras UAB: FDA inspection ending Jan 31, 2024
FDA inspection 1236460 · Official Action Indicated (OAI) · Vilnius
Key facts
| Inspection ID | 1236460 |
|---|---|
| Firm | Biotechpharma Biotechnologines Farmacijos Centras UAB |
| FEI number | 3013580461 |
| Address | Mokslininku G. 4 |
| City | Vilnius |
| Fiscal year | 2024 |
| Inspection end date | Jan 31, 2024 |
| Classification | Official Action Indicated (OAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data